| Deborah Mccollum, MD | |
|
6611 W Amarillo Blvd, Amarillo, TX 79106-1755 | |
| (806) 212-4535 | |
| (806) 212-4555 |
| Full Name | Deborah Mccollum |
|---|---|
| Gender | Female |
| Speciality | Thoracic Surgery |
| Experience | 36 Years |
| Location | 6611 W Amarillo Blvd, Amarillo, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144260837 | NPI | - | NPPES |
| 0049HR | Other | TX | BLUECROSS/BLUESHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | J8313 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Terrebonne General Medical Center | Houma, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Paeon Health Services Inc | 1153697727 | 41 |
News Archive
An international group of experts on Negative Pressure Wound Therapy (NPWT) will assemble this week to develop a comprehensive, evidence-based consensus on the use of NPWT. The International NPWT Expert Panel is drafting recommendations for a range of NPWT indications and techniques that reflect the body of NPWT published clinical evidence.
Researchers led by Arizona State University and the Translational Genomics Research Institute have identified altered expression of a gene called ANK1, which only recently has been associated with memory robbing Alzheimer's disease, in specific cells in the brain.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
Tiny particles of iron oxide could become tools for simultaneous tumor imaging and treatment, because of their magnetic properties and toxic effects against brain cancer cells. In mice, researchers from Emory University School of Medicine have demonstrated how these particles can deliver antibodies to implanted brain tumors, while enhancing tumor visibility via magnetic resonance imaging (MRI).
A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.
› Verified 3 days ago
| Entity Name | Satyr Clinical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881019321 PECOS PAC ID: 2466673025 Enrollment ID: O20141023000763 |
News Archive
An international group of experts on Negative Pressure Wound Therapy (NPWT) will assemble this week to develop a comprehensive, evidence-based consensus on the use of NPWT. The International NPWT Expert Panel is drafting recommendations for a range of NPWT indications and techniques that reflect the body of NPWT published clinical evidence.
Researchers led by Arizona State University and the Translational Genomics Research Institute have identified altered expression of a gene called ANK1, which only recently has been associated with memory robbing Alzheimer's disease, in specific cells in the brain.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
Tiny particles of iron oxide could become tools for simultaneous tumor imaging and treatment, because of their magnetic properties and toxic effects against brain cancer cells. In mice, researchers from Emory University School of Medicine have demonstrated how these particles can deliver antibodies to implanted brain tumors, while enhancing tumor visibility via magnetic resonance imaging (MRI).
A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.
› Verified 3 days ago
| Entity Name | Paeon Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568985612 PECOS PAC ID: 1153697727 Enrollment ID: O20171026000630 |
News Archive
An international group of experts on Negative Pressure Wound Therapy (NPWT) will assemble this week to develop a comprehensive, evidence-based consensus on the use of NPWT. The International NPWT Expert Panel is drafting recommendations for a range of NPWT indications and techniques that reflect the body of NPWT published clinical evidence.
Researchers led by Arizona State University and the Translational Genomics Research Institute have identified altered expression of a gene called ANK1, which only recently has been associated with memory robbing Alzheimer's disease, in specific cells in the brain.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
Tiny particles of iron oxide could become tools for simultaneous tumor imaging and treatment, because of their magnetic properties and toxic effects against brain cancer cells. In mice, researchers from Emory University School of Medicine have demonstrated how these particles can deliver antibodies to implanted brain tumors, while enhancing tumor visibility via magnetic resonance imaging (MRI).
A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Mccollum, MD Po Box 840026, Dallas, TX 75284-0026 Ph: (806) 212-6965 | Deborah Mccollum, MD 6611 W Amarillo Blvd, Amarillo, TX 79106-1755 Ph: (806) 212-4535 |
News Archive
An international group of experts on Negative Pressure Wound Therapy (NPWT) will assemble this week to develop a comprehensive, evidence-based consensus on the use of NPWT. The International NPWT Expert Panel is drafting recommendations for a range of NPWT indications and techniques that reflect the body of NPWT published clinical evidence.
Researchers led by Arizona State University and the Translational Genomics Research Institute have identified altered expression of a gene called ANK1, which only recently has been associated with memory robbing Alzheimer's disease, in specific cells in the brain.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
Tiny particles of iron oxide could become tools for simultaneous tumor imaging and treatment, because of their magnetic properties and toxic effects against brain cancer cells. In mice, researchers from Emory University School of Medicine have demonstrated how these particles can deliver antibodies to implanted brain tumors, while enhancing tumor visibility via magnetic resonance imaging (MRI).
A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.
› Verified 3 days ago
Shamini Parameswaran, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 6611 W Amarillo Blvd, Amarillo, TX 79106 Phone: 806-212-4535 Fax: 806-212-4555 |